Article Details
Retrieved on: 2018-03-05 22:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Its investors include GV (formerly <b>Google Ventures</b>), which last year led a $50 million Series B financing that included participation from Third Rock and Atlas, as well as Partners Innovation Fund, Access Industries, Casdin Capital and Be The Match BioTherapies, a subsidiary of National Marrow Donor ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here